View in EDS PDF Full Text

Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant.

Saved in:
Bibliographic Details
Title: Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant.
Authors: Eytan K; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel., Versano Z; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Oren R; Department of Veterinary Resources, The Weizmann Institute of Science, Rehovot, Israel., Jacob-Hirsch J; Sheba Cancer Research Center (SCRC), Chaim Sheba Medical Center, Ramat Gan, Israel.; Wohl Centre for Translational Medicine, Chaim Sheba Medical Center, Ramat Gan, Israel., Leitner M; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel., Harmelin A; Department of Veterinary Resources, The Weizmann Institute of Science, Rehovot, Israel., Rechavi G; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sheba Cancer Research Center (SCRC), Chaim Sheba Medical Center, Ramat Gan, Israel.; Wohl Centre for Translational Medicine, Chaim Sheba Medical Center, Ramat Gan, Israel., Toren A; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Paglin S; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel., Yalon M; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.; Chaim Sheba Medical Center, Ramat Gan, Israel.
Source: Frontiers in oncology [Front Oncol] 2022 Aug 26; Vol. 12, pp. 959133. Date of Electronic Publication: 2022 Aug 26 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36091130
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Eytan+K%22">Eytan K</searchLink>; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Versano+Z%22">Versano Z</searchLink>; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Oren+R%22">Oren R</searchLink>; Department of Veterinary Resources, The Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Jacob-Hirsch+J%22">Jacob-Hirsch J</searchLink>; Sheba Cancer Research Center (SCRC), Chaim Sheba Medical Center, Ramat Gan, Israel.; Wohl Centre for Translational Medicine, Chaim Sheba Medical Center, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Leitner+M%22">Leitner M</searchLink>; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Harmelin+A%22">Harmelin A</searchLink>; Department of Veterinary Resources, The Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Rechavi+G%22">Rechavi G</searchLink>; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Sheba Cancer Research Center (SCRC), Chaim Sheba Medical Center, Ramat Gan, Israel.; Wohl Centre for Translational Medicine, Chaim Sheba Medical Center, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Toren+A%22">Toren A</searchLink>; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Paglin+S%22">Paglin S</searchLink>; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Yalon+M%22">Yalon M</searchLink>; Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital and Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel.; Chaim Sheba Medical Center, Ramat Gan, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Aug 26; Vol. 12, pp. 959133. <i>Date of Electronic Publication: </i>2022 Aug 26 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36091130
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2022.959133
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 959133
    Titles:
      – TitleFull: Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Eytan K
      – PersonEntity:
          Name:
            NameFull: Versano Z
      – PersonEntity:
          Name:
            NameFull: Oren R
      – PersonEntity:
          Name:
            NameFull: Jacob-Hirsch J
      – PersonEntity:
          Name:
            NameFull: Leitner M
      – PersonEntity:
          Name:
            NameFull: Harmelin A
      – PersonEntity:
          Name:
            NameFull: Rechavi G
      – PersonEntity:
          Name:
            NameFull: Toren A
      – PersonEntity:
          Name:
            NameFull: Paglin S
      – PersonEntity:
          Name:
            NameFull: Yalon M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 08
              Text: 2022 Aug 26
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1